Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China · Delayed Price · Currency is CNY

12.51

-0.11 (-0.87%)

Sep 10, 2026, 3:04 PM CST

Market Cap	10.41B -23.1%
Revenue (ttm)	2.67B -5.8%
Net Income	200.72M +24.9%
EPS	0.24 +25.3%
Shares Out	824.60M
PE Ratio	51.71
Forward PE	29.35
Dividend	0.08 (0.62%)
Ex-Dividend Date	Apr 29, 2026

Volume	5,071,968
Open	12.90
Previous Close	12.62
Day's Range	12.50 - 12.90
52-Week Range	12.05 - 16.43
Beta	-0.12
Analysts	Buy
Price Target	17.75 (+41.89%)
Earnings Date	Aug 22, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 2,583

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002675

Full Company Profile

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 002675 stock is "Buy." The 12-month stock price target is ¥17.75, which is an increase of 41.89% from the latest price.

Price Target

¥17.75

(41.89% upside)

Analyst Consensus: Buy

Stock Forecasts